Age-dependency of Cornea Biomechanics Using OCT Vibrography

Cornea Clinical Trial

Official title:

Age-dependency of Cornea Biomechanics Measured by OCT Vibrography: A Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03230981
• Other study ID #: 2017P000867
• Status: Completed
• Phase: N/A
• Start date: August 1, 2019
• Est. completion date: January 1, 2023

Study information

• Verified date: January 2023
• Source: Massachusetts General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this pilot study is to assess the ability of a new optical coherence tomography system to obtain information on biomechanics of the cornea.

Description:

The cornea, the clear front window of the eye, consists of finely intertwined collagen fibers, which give the cornea a microstructure that provides mechanical integrity necessary to maintain its typical dome-shape against the intraocular pressure (IOP). Changes in the biomechanical properties can lead to an abnormal corneal shape and refractive errors. As a result, light is not perfectly focused onto the retina and the vision is affected. A typical example of alterations in the cornea's biomechanical properties is found in patients with an eye disorder called Keratoconus, which leads to progressive thinning of the cornea. Numerous studies have shown that promising interventions like collagen crosslinking (CXL) can slow down an arrest progression of ectatic eye diseases. Keratoconus, as a typical example, although it cannot be cured, could be at least halted by CXL. Therefore, early diagnosis of ectasia is crucial for the patient. Current diagnostic methods of ectasia are based on morphological rather than biomechanical analysis. The irregular patterns of the cornea can be detected by pachymetry and topography before clinical signs occur, but these tests cannot reliably differentiate truly weak or keratoconic corneas from atypical normal ones. These are compelling needs for improved diagnostic methods. More recently, and triggered by those unmet needs, an interest in the mechanical properties of the cornea has emerged. Typical examples of mechanical properties are elastic modulus and corneal stiffness. In this pilot study the investigators will test the ability of a new OCT Vibrography system to determine cornea material parameters. More precisely, the investigators will study the oscillation response in human corneas in-vivo using a stimulus mechanism used to induce vibrations by touching the surface of the cornea. A localized vibration source paired together with phase-sensitive OCT to measure the frequency response function of the human cornea and to analyze the dependency of the frequency response function on age. Additionally the investigators will use Brillouin Microscopy data for computer simulations to validate OCT Vibrography results.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: January 1, 2023
• Est. primary completion date: January 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 79 Years

Eligibility

Inclusion Criteria:

• Male or female subjects between the ages of 18 to 79 years
• Healthy normal subjects with no significant eye disease and no significant refractive errors

Exclusion Criteria:

• Volunteers with implanted intraocular lenses
• Volunteers with LASIK or any other eye surgery, and monocular volunteers
• Volunteers with restricted mobility, who cannot stand up, walk or sit still on a chair without a back
• Subjects who do not or cannot understand the instructions for imaging
• Subjects with diabetes, glaucoma family history
• Subjects who are pregnant and/or breastfeeding.

Related Conditions & MeSH terms

• Cornea
• Corneal Diseases

Intervention

Device:
• Optical imaging of the cornea in healthy subjects
OCT vibrography and Brillouin microscopy

Locations

Country	Name	City	State
United States	Massachusetts General Hospital	Boston	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
Massachusetts General Hospital	Massachusetts Eye and Ear Infirmary

Country where clinical trial is conducted

United States, 

References & Publications (3)

de Sanctis U, Loiacono C, Richiardi L, Turco D, Mutani B, Grignolo FM. Sensitivity and specificity of posterior corneal elevation measured by Pentacam in discriminating keratoconus/subclinical keratoconus. Ophthalmology. 2008 Sep;115(9):1534-9. doi: 10.1016/j.ophtha.2008.02.020. Epub 2008 Apr 11. — View Citation

Li X, Rabinowitz YS, Rasheed K, Yang H. Longitudinal study of the normal eyes in unilateral keratoconus patients. Ophthalmology. 2004 Mar;111(3):440-6. doi: 10.1016/j.ophtha.2003.06.020. — View Citation

Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003 May;135(5):620-7. doi: 10.1016/s0002-9394(02)02220-1. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of subjects to successfully complete OCT Vibrography without serious unanticipated adverse events related to application of the device.	Frequency and severity of all treatment-related adverse events	1 year
Secondary	Validation of OCT Vibrography data by means of Brillouin microscopy measurements of the in-vivo cornea	Use of Brillouin microscopy in-vivo data for computer simulations to validate OCT Vibrography results.	1 year